Pfizer will start testing its coronavirus vaccine on children as young as 12, a crucial step to bringing the shot to more people
Pfizer is setting plans to make its coronavirus vaccine available to more groups of people, should the pharma company prove that the shot works to prevent the virus. On Monday, the company said on its website that it got approval from regulators to expand a trial of the shot to include children as young as 12, becoming the first major drugmaker to open a coronavirus vaccine trial to kids. A Pfizer spokesperson said it also got permission to expand the study to include as many as 48,400 volunteers, 10% larger than the previous cap.
Source: Business Insider